Library

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Oxford UK : Blackwell Science Ltd.
    Journal of neurochemistry 74 (2000), S. 0 
    ISSN: 1471-4159
    Source: Blackwell Publishing Journal Backfiles 1879-2005
    Topics: Medicine
    Notes: Abstract:κ-Opioid receptor agonists prevent alterations indopamine neurotransmission that occur in response to repeated cocaineadministration. The present microdialysis study examined whetheradministration of the selective κ-opioid receptor agonist U69593 withmethamphetamine prevents alterations in dopamine levels produced by neurotoxicdoses of methamphetamine. Swiss Webster mice were injected intraperitoneallywith methamphetamine (10.0 mg/kg) or saline, four times in 1 day, at 2-hintervals. Prior to the first and third injection, they received U69593 (0.32mg/kg s.c.) or vehicle. Microdialysis was conducted 3, 7, or 21 days later.Basal and K+-evoked (60 and 100 mM) dopamine overflow werereduced 3 days after methamphetamine administration. These effects werelong-lasting in that they were still apparent 7 and 21 days aftermethamphetamine treatment. Intrastriatal (5.0 and 50 μM) orsystemic (1.0-10.0 mg/kg) administration of methamphetamine increased dopamineconcentrations in control animals. In mice preexposed to methamphetamine,methamphetamine-evoked dopamine overflow was reduced. In animals that hadreceived methamphetamine with U69593, basal dopamine levels did not differfrom those of vehicle-treated controls. U69593 treatment attenuated thedecrease in K+-evoked dopamine produced by prior methamphetamine exposure. The reduction in methamphetamine-evoked dopamine levels was also attenuated. The administration of U69593 alone did not modify basal or stimulus-evoked dopamine levels. These data demonstrate that repeated methamphetamine administration reduces presynaptic dopamine neuronal function in mouse striatum and that co-administration of a selective κ-opioid receptor agonist with methamphetamine attenuates these effects. U69593 treatment did not modify the hyperthermic effects of methamphetamine, indicating that this κ-opioid receptor agonist selectively attenuates methamphetamine-induced alterations in dopamine neurotransmission.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...